Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Yuko Kinashi"'
Autor:
Natsuko Kondo, Akihisa Takahashi, Eiichiro Mori, Taichi Noda, Małgorzata Z Zdzienicka, Larry H Thompson, Thomas Helleday, Minoru Suzuki, Yuko Kinashi, Shinichiro Masunaga, Koji Ono, Masatoshi Hasegawa, Takeo Ohnishi
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e19659 (2011)
Nimustine (ACNU) and temozolomide (TMZ) are DNA alkylating agents which are commonly used in chemotherapy for glioblastomas. ACNU is a DNA cross-linking agent and TMZ is a methylating agent. The therapeutic efficacy of these agents is limited by the
Externí odkaz:
https://doaj.org/article/f9a437c8a95f4827a47ed7a9f98dae7c
Autor:
Natsuko Kondo, Akihisa Takahashi, Eiichiro Mori, Taichi Noda, Małgorzata Z. Zdzienicka, Larry H. Thompson, Thomas Helleday, Minoru Suzuki, Yuko Kinashi, Shinichiro Masunaga, Koji Ono, Masatoshi Hasegawa, Takeo Ohnishi
Publikováno v:
PLoS ONE, Vol 6, Iss 6 (2011)
Externí odkaz:
https://doaj.org/article/2c395d7258c147c5af00bb9791743477
Publikováno v:
Anticancer Research. 43:1455-1461
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51c322c64e0bdf48af6561be92ba5741
https://doi.org/10.21873/anticanres.16294
https://doi.org/10.21873/anticanres.16294
Autor:
Tsubasa Watanabe, Tomohiro Yoshikawa, Hiroki Tanaka, Yuko Kinashi, Genro Kashino, Shin-ichiro Masunaga, Toshimitsu Hayashi, Koki Uehara, Koji Ono, Minoru Suzuki
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6920cc928be9b9a299550dc7b94efa7
https://doi.org/10.1007/s13318-023-00830-y
https://doi.org/10.1007/s13318-023-00830-y
Autor:
Satoshi Mizuno, Mitsuyuki Konno, Sentaro Takahashi, Tomoyuki Takahashi, Yuko Kinashi, Sota Tanaka, Takumi Kubota, Kayoko Iwata, Satoshi Fukutani
Publikováno v:
Japanese Journal of Health Physics. 54:66-71
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c4046fb8491218c75258d78317af39d
https://doi.org/10.5453/jhps.54.66
https://doi.org/10.5453/jhps.54.66
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 163
Temozolomide (TMZ) is a DNA-alkylating agent used for chemo-radiotherapy of glioblastoma, which is also a target cancer for boron neutron capture therapy (BNCT). Although the DNA-repair enzyme O6-methylguanine DNA methyltransferase (MGMT) and the tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e064a812ef00a1164892e467855d4a2
https://pubmed.ncbi.nlm.nih.gov/32561044
https://pubmed.ncbi.nlm.nih.gov/32561044
Autor:
Masayuki Morishita, Minoru Suzuki, Toshihiro Akisue, Shunsuke Sakakibara, Takuya Fujimoto, Yoshinori Sakurai, Ikuo Fujita, Tomoyuki Matsumoto, Setsu Sakamoto, Teruya Kawamoto, Yuko Kinashi, Hiroshi Igaki, Toshiko Sakuma, Hiroki Tanaka, Yohei Kawakami, Yuki Tamari, Yuta Nakamatsu, Tamotsu Sudo, Hideki Ichikawa, Shin-ichiro Masunaga, Tooru Andoh, Natsuko Kondo, Koji Ono, Shigeyuki Kuratsu, Tadashi Watabe, Takushi Takata, Hitomi Hara, Ryosuke Kuroda, Naomasa Fukase, Takanori Hirose
Publikováno v:
Applied Radiation and Isotopes. 169:109407
Synovial sarcoma is a rare tumor requiring new treatment methods. A 46-year-old woman with primary monophasic synovial sarcoma in the left thigh involving the sciatic nerve, declining surgery because of potential dysfunction of the affected limbs, re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d1d65c63a19403257e4fbeeb5606438
https://doi.org/10.1016/j.apradiso.2020.109407
https://doi.org/10.1016/j.apradiso.2020.109407
Autor:
Akira Maruhashi, Hiroki Tanaka, Minoru Suzuki, Yuko Kinashi, Takushi Takata, Koji Ono, Shinji Kawabata, Tsubasa Watanabe, T. Mitsumoto, Y. Sakurai, S. Masunaga
Publikováno v:
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 983:164533
The development of a new boron compound for boron neutron capture therapy (BNCT) requires a high-intensity thermal neutron beam and the construction of thermal neutron fields in place of research reactors scheduled for suspension in the future. A the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca97f53f01815b7d096fbbb87791346b
https://doi.org/10.1016/j.nima.2020.164533
https://doi.org/10.1016/j.nima.2020.164533
Autor:
Shin-ichiro Masunaga, Hiroki Tanaka, Tsubasa Watanabe, Hiroyuki Michiue, Yosuke Nakagawa, Masaru Narabayashi, Yoshinori Sakurai, Minoru Suzuki, Koji Ono, Natsuko Kondo, Yuko Kinashi
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 21:108-112
Aim In this study, we investigated γH2AX foci as markers of DSBs in normal brain and brain tumor tissue in mouse after BNCT. Background Boron neutron capture therapy (BNCT) is a particle radiation therapy in combination of thermal neutron irradiatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0417d367694a7c3e347d3d6dc6ef3504
https://doi.org/10.1016/j.rpor.2014.10.005
https://doi.org/10.1016/j.rpor.2014.10.005
Autor:
Masaru Narabayashi, Hiroki Tanaka, Yoshinori Sakurai, Natsuko Kondo, Yuko Kinashi, Tsubasa Watanabe, Koji Ono, Shin-ichiro Masunaga, Yoshiaki Nakagawa, Minoru Suzuki, Takushi Takata, Akira Maruhashi, N. Fujimoto
Publikováno v:
Applied Radiation and Isotopes. 106:134-138
It is important that improvements are made to depth dose distribution in boron neutron capture therapy, because the neutrons do not reach the innermost regions of the human body. Here, we evaluated the dose distribution obtained using multiple-field
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd3551492c874e878c34619ec9d3978c
https://doi.org/10.1016/j.apradiso.2015.07.041
https://doi.org/10.1016/j.apradiso.2015.07.041